Heather Harris
Family Medicine · Las Vegas, NVNPI 1528223906
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 298 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AstraZeneca at 29.3% of the total. Among family medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 298 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$1K
- Boehringer Ingelheim$656
- Novo Nordisk$437
- Abbott$342
- Astellas Pharma US Inc$235
- plus $888 from 20 others
What the payments were for
- Food & beverage$5,038100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 76 | $1,476 |
| AbbVie | 66 | $1,004 |
| Boehringer Ingelheim | 47 | $656 |
| Novo Nordisk | 20 | $437 |
| Abbott | 21 | $342 |
| Astellas Pharma US Inc | 12 | $235 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $131 |
| Pfizer | 7 | $102 |
| Novartis | 5 | $77 |
| Exact Sciences | 4 | $70 |
| Viiv Healthcare Company | 3 | $64 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Biohaven Pharmaceuticals, Inc. | 4 | $53 |
| Merck | 3 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $45 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Amgen | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Bayer | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| GSK | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,038 in reported general payments places this provider in the 90th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 62 | $48,909 |
| FarxigaDapagliflozin Propanediol | 46 | $45,644 |
| OzempicSemaglutide | 34 | $39,559 |
| MounjaroTirzepatide | 26 | $31,145 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $16,947 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $8,181 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,129 |
| SynthroidLevothyroxine Sodium | 29 | $2,357 |
| Atorvastatin Calcium | 302 | $2,070 |
| Losartan Potassium | 194 | $1,616 |
| Levothyroxine Sodium | 175 | $1,522 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $1,090 |
| Metoprolol Succinate | 90 | $941 |
| Gabapentin | 59 | $882 |
| Amlodipine Besylate | 167 | $868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $1,476 | $62,59163 claims |
| PfizerEliquis | $102 | $48,90962 claims |
| Novo NordiskOzempic | $437 | $39,55934 claims |
| Lilly USA, LLCMounjaro | $13 | $31,14526 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $18 | $16,31026 claims |
| AbbVieSynthroid, Armour Thyroid | $1,004 | $3,22240 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 902 family medicine providers in Nevada.
Other family medicine in Las Vegas
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Warren MagnusLas Vegas$70K
- Kimberly AdamsLas Vegas$51K
- Mandeep GillLas Vegas$24K
- Francis JimenezLas Vegas$20K
- Ryan HuangLas Vegas$18K
- Ma Francesca ChamianLas Vegas$17K
- Leo CapobiancoLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.